Engineers Gate Manager’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,023
| Closed | -$8.57K | – | 2685 |
|
|
2024
Q4 | $8.57K | Sell |
16,023
-13,459
| -46% | -$9.38K | ﹤0.01% | 2171 |
|
|
2024
Q3 | $51.9K | Buy |
29,482
+8,454
| +40% | +$11.8K | ﹤0.01% | 1977 |
|
|
2024
Q2 | $24.6K | Buy |
+21,028
| New | +$52.6K | ﹤0.01% | 1845 |
|
|
2023
Q3 | – | Sell |
-19,874
| Closed | -$216K | – | 2146 |
|
|
2023
Q2 | $216K | Buy |
+19,874
| New | +$170K | 0.01% | 1446 |
|
|
2021
Q2 | – | Sell |
-13,325
| Closed | -$206K | – | 2115 |
|
|
2021
Q1 | $206K | Buy |
+13,325
| New | +$193K | 0.01% | 1583 |
|
|
2020
Q3 | – | Sell |
-25,132
| Closed | -$255K | – | 2041 |
|
|
2020
Q2 | $255K | Buy |
+25,132
| New | +$231K | 0.01% | 1299 |
|
|
2020
Q1 | – | Sell |
-14,690
| Closed | -$127K | – | 2019 |
|
|
2019
Q4 | $127K | Buy |
14,690
+23
| +0.2% | +$129 | 0.01% | 1525 |
|
|
2019
Q3 | $90K | Sell |
14,667
-2,038
| -12% | -$16.5K | ﹤0.01% | 1316 |
|
|
2019
Q2 | $277K | Sell |
16,705
-9,971
| -37% | -$173K | 0.02% | 893 |
|
|
2019
Q1 | $446K | Sell |
26,676
-10,686
| -29% | -$154K | 0.03% | 637 |
|
|
2018
Q4 | $429K | Buy |
+37,362
| New | +$756K | 0.03% | 563 |
|
Engineers Gate Manager's MRNS Position: Q1 2025 in Review
Engineers Gate Manager sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 16,023 shares — an estimated $8.57K sold.
Engineers Gate Manager first reported a position in MRNS in Q4 2018 and held it in 11 quarters. The position peaked at $446K in Q1 2019. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.
- Engineers Gate Manager reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
- Engineers Gate Manager sold 16,023 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $8.57K.
- Engineers Gate Manager first reported a position in Marinus Pharmaceuticals, Inc in Q4 2018 and held it in 11 quarters.
- Engineers Gate Manager's Marinus Pharmaceuticals, Inc position peaked at $446K in Q1 2019.
- 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.
Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.